UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 2 |
UBS Group
UBS
|
+$643M |
| 3 |
Southwest Airlines
LUV
|
+$588M |
| 4 |
Medtronic
MDT
|
+$505M |
| 5 |
Workday
WDAY
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.51B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$976M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$803M |
| 5 |
Chevron
CVX
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.35% |
| 2 | Technology | 17.79% |
| 3 | Financials | 9.18% |
| 4 | Industrials | 6.66% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CPSP
7526
Calamos S&P 500 Structured Alt Protection ETF - April
CPSP
$24.5M
| $51.3K | ﹤0.01% |
1,992
+491
| +33% | +$12.5K |
2025 Q2
1 quarter
|
|
7527
Franklin FTSE South Korea ETF
FLKR
$1.72B
| $51.3K | ﹤0.01% |
1,900
+900
| +90% | +$22.7K |
2025 Q2
1 quarter
|
|
7528
Innovator Equity Defined Protection ETF - 2 Yr to July 2027
TJUL
$116M
| $51.3K | ﹤0.01% |
1,751
-28,641
| -94% | -$830K |
2024 Q1
6 quarters
|
|
|
THNR
7529
Amplify Weight Loss Drug & Treatment ETF
THNR
$5.68M
| $51.1K | ﹤0.01% |
2,184
-369
| -14% | -$8.48K |
2024 Q3
4 quarters
|
|
7530
Truth Social America First ETF
MAGA
$29.6M
| $51.1K | ﹤0.01% |
972
+742
| +323% | +$38.4K |
2025 Q2
1 quarter
|
|
7531
Tiziana Life Sciences
TLSA
$145M
| $51K | ﹤0.01% |
23,630
+19,341
| +451% | +$35.8K |
2021 Q2
17 quarters
|
|
|
KAZR
7532
Skyline Builders Group
KAZR
$43.6M
| $51K | ﹤0.01% |
14,922
+7,823
| +110% | +$15.3K |
2025 Q1
2 quarters
|
|
|
ACCS
7533
ACCESS Newswire
ACCS
$18.3M
| $51K | ﹤0.01% |
4,755
-3
| -0.1% | -$34 |
2024 Q4
3 quarters
|
|
|
LLYX
7534
Defiance Daily Target 2x Long LLY ETF
LLYX
$42.1M
| $51K | ﹤0.01% |
3,673
-15,013
| -80% | -$208K |
2025 Q1
2 quarters
|
|
7535
Outlook Therapeutics
OTLK
$140M
| $51K | ﹤0.01% |
48,114
-7,010
| -13% | -$12.1K |
2023 Q4
7 quarters
|
|
7536
Spero Therapeutics
SPRO
$73.4M
| $51K | ﹤0.01% |
27,101
+18,907
| +231% | +$41.6K |
2019 Q2
25 quarters
|
|
7537
Worksport
WKSP
$7.04M
| $50.9K | ﹤0.01% |
14,663
+14,238
| +3,350% | +$49.3K |
2024 Q4
3 quarters
|
|
7538
VirnetX Holding Corp
VHC
$39.4M
| $50.8K | ﹤0.01% |
2,821
-4,523
| -62% | -$72.2K |
2014 Q4
43 quarters
|
|
7539
Innovator US Small Cap Power Buffer ETF October
KOCT
$129M
| $50.7K | ﹤0.01% |
1,535
-16,903
| -92% | -$535K |
2025 Q1
2 quarters
|
|
|
JEMB
7540
Janus Henderson Emerging Markets Debt Hard Currency ETF
JEMB
$466M
| $50.6K | ﹤0.01% |
952
-237
| -20% | -$12.4K |
2025 Q2
1 quarter
|
|
|
PHOE
7541
Phoenix Asia Holdings
PHOE
$389M
| $50.6K | ﹤0.01% |
5,681
+848
| +18% | +$6.96K |
2025 Q2
1 quarter
|
|
|
MAXN
7542
DELISTED
Maxeon Solar Technologies
MAXN
| $50.6K | ﹤0.01% |
15,090
-31,597
| -68% | -$123K |
2024 Q4
3 quarters
|
|
|
UXIN
7543
Uxin Ltd
UXIN
$301M
| $50.5K | ﹤0.01% |
14,607
+12,828
| +721% | +$49K |
2024 Q4
3 quarters
|
|
7544
Direxion Daily Energy Bear 2X ETF
ERY
$40.8M
| $50.5K | ﹤0.01% |
2,493
+2,247
| +913% | +$48.2K |
2021 Q4
15 quarters
|
|
|
ELP
7545
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $50.5K | ﹤0.01% |
5,150
-12,807
| -71% | -$115K |
2014 Q4
43 quarters
|
|
7546
Dermata Therapeutics
DRMA
$5.5M
| $50.4K | ﹤0.01% |
10,047
+951
| +10% | +$5.78K |
2024 Q2
5 quarters
|
|
7547
CALL
Antero Resources
AR
$10.5B
| $50.3K | ﹤0.01% |
+1,500
| New | +$50K |
2025 Q3
0 quarters
|
|
7548
ProShares S&P 500 ex-Technology ETF
SPXT
$279M
| $50.3K | ﹤0.01% |
+499
| New | +$49K |
2025 Q3
0 quarters
|
|
|
LPA
7549
Logistic Properties of the Americas
LPA
$92.2M
| $50K | ﹤0.01% |
10,740
-472
| -4% | -$3.01K |
2024 Q4
3 quarters
|
|
|
IAF
7550
abrdn Australia Equity Fund
IAF
$118M
| $50K | ﹤0.01% |
3,633
-674
| -16% | -$9.21K |
2014 Q4
43 quarters
|
|
Similar funds
UBS Group's Q3 2025 Portfolio in Review
As of Q3 2025, UBS Group held 11,340 positions worth $638B, up 11% from $578B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group's Q3 2025 filing shows 1,171 new, 4,183 increased, 4,475 reduced and 1,086 closed positions. Its largest new stake was Paramount Skydance Corp: 13,287,677 shares worth $251M. The largest sale was NVIDIA, an estimated $1.51B.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q3 2025 buy was Paramount Skydance Corp: 13,287,677 shares worth $251M.
- UBS Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.08B increase.
- UBS Group's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.51B.
- UBS Group fully exited Hess in Q3 2025, selling an estimated $442M.
- UBS Group's ten largest holdings make up 16% of its $638B portfolio in Q3 2025.
- UBS Group opened 1,171 new positions and closed 1,086 in Q3 2025.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $638B.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.